166 related articles for article (PubMed ID: 35965138)
1. Ten-year follow-up of lung cancer patients with resected adenocarcinoma in situ or minimally invasive adenocarcinoma: Wedge resection is curative.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
J Thorac Cardiovasc Surg; 2022 Dec; 164(6):1614-1622.e1. PubMed ID: 35965138
[TBL] [Abstract][Full Text] [Related]
2. Surgery for pre- and minimally invasive lung adenocarcinoma.
Zhang Y; Ma X; Shen X; Wang S; Li Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2022 Feb; 163(2):456-464. PubMed ID: 33485660
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Prognosis of Patients With Resected Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma of the Lung.
Yotsukura M; Asamura H; Motoi N; Kashima J; Yoshida Y; Nakagawa K; Shiraishi K; Kohno T; Yatabe Y; Watanabe SI
J Thorac Oncol; 2021 Aug; 16(8):1312-1320. PubMed ID: 33915249
[TBL] [Abstract][Full Text] [Related]
4. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
5. [Clinical Efficacy Analysis of Wedge Resection of Pulmonary
in Patients with Small Volume Invasive Lung Adenocarcinoma].
Cui S; Wang G; Huang Z; Wu M; Wu H; Zhou H; Xu M; Xie M
Zhongguo Fei Ai Za Zhi; 2024 May; 27(5):359-366. PubMed ID: 38880923
[TBL] [Abstract][Full Text] [Related]
6. Ten-Year Follow-up Results of Pure Ground-Glass Opacity-Featured Lung Adenocarcinomas After Surgery.
Li D; Deng C; Wang S; Li Y; Zhang Y; Chen H
Ann Thorac Surg; 2023 Aug; 116(2):230-237. PubMed ID: 36646243
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of metachronous multiple lung adenocarcinoma at the cut-end by epidermal growth factor receptor mutation status discordance 4 years after sublobar resection for adenocarcinoma in situ: report of a case.
Isaka T; Yokose T; Ito H; Imamura N; Watanabe M; Imai K; Nishii T; Yamada K; Nakayama H; Masuda M
Surg Today; 2015 Oct; 45(10):1330-4. PubMed ID: 25377270
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outcomes following lobectomy, segmentectomy, and wedge resection based on pathological subtyping in patients with pN0 invasive lung adenocarcinoma ≤1 cm.
Song W; Hou Y; Zhang J; Zhou Q
Cancer Med; 2022 Dec; 11(24):4784-4795. PubMed ID: 35570370
[TBL] [Abstract][Full Text] [Related]
9. Lung Adenocarcinoma Invasiveness Risk in Pure Ground-Glass Opacity Lung Nodules Smaller than 2 cm.
Lee GD; Park CH; Park HS; Byun MK; Lee IJ; Kim TH; Lee S
Thorac Cardiovasc Surg; 2019 Jun; 67(4):321-328. PubMed ID: 29359309
[TBL] [Abstract][Full Text] [Related]
10. Second primary lung cancer and relapse: treatment and follow-up.
Angeletti CA; Mussi A; Janni A; Lucchi M; Ribechini A; Chella A; Fontanini G
Eur J Cardiothorac Surg; 1995; 9(11):607-11. PubMed ID: 8751247
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a model for predicting upstage in minimally invasive lung adenocarcinoma in Chinese people.
Liao Y; Li Z; Song L; Xue Y; Chen X; Feng G
World J Surg Oncol; 2024 May; 22(1):135. PubMed ID: 38778366
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor Receptor Mutation as a Risk Factor for Recurrence in Lung Adenocarcinoma.
Hayasaka K; Shiono S; Matsumura Y; Yanagawa N; Suzuki H; Abe J; Sagawa M; Sakurada A; Katahira M; Takahashi S; Endoh M; Okada Y
Ann Thorac Surg; 2018 Jun; 105(6):1648-1654. PubMed ID: 29486179
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of lung adenocarcinoma predominance classification relating to pathological factors in lobectomy, the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Ito H; Date H; Shintani Y; Miyaoka E; Nakanishi R; Kadokura M; Endo S; Chida M; Yoshino I; Suzuki H;
BMC Cancer; 2022 Aug; 22(1):875. PubMed ID: 35948946
[TBL] [Abstract][Full Text] [Related]
14. Surgery for young patients with lung cancer.
Tian DL; Liu HX; Zhang L; Yin HN; Hu YX; Zhao HR; Chen DY; Han LB; Li Y; Li HW
Lung Cancer; 2003 Nov; 42(2):215-20. PubMed ID: 14568689
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
Xu Y; Zheng M; Wang N; Wang R
Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
[TBL] [Abstract][Full Text] [Related]
16. Propensity-Matched Analysis Comparing Survival After Sublobar Resection and Lobectomy for cT1N0 Lung Adenocarcinoma.
Chiang XH; Hsu HH; Hsieh MS; Chang CH; Tsai TM; Liao HC; Tsou KC; Lin MW; Chen JS
Ann Surg Oncol; 2020 Mar; 27(3):703-715. PubMed ID: 31646453
[TBL] [Abstract][Full Text] [Related]
17. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
[TBL] [Abstract][Full Text] [Related]
18. Positive EGFR mutation status is a risk of recurrence in pN0-1 lung adenocarcinoma when combined with pathological stage and histological subtype: A retrospective multi-center analysis.
Ito M; Miyata Y; Tsutani Y; Ito H; Nakayama H; Imai K; Ikeda N; Okada M
Lung Cancer; 2020 Mar; 141():107-113. PubMed ID: 32035371
[TBL] [Abstract][Full Text] [Related]
19. Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma.
Voltolini L; Paladini P; Luzzi L; Ghiribelli C; Di Bisceglie M; Gotti G
Eur J Cardiothorac Surg; 2000 Nov; 18(5):529-34. PubMed ID: 11053812
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection.
Jeon JH; Kang CH; Kim HS; Seong YW; Park IK; Kim YT
Eur J Cardiothorac Surg; 2015 Mar; 47(3):556-62. PubMed ID: 24760387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
